Loading organizations...
Loading organizations...
Biopharmaceutical company developing drugs for metabolic diseases.
Poxel has raised $50.3M across 3 funding rounds.
Poxel has raised $50.3M in total across 3 funding rounds.
Poxel has raised $50.3M in total across 3 funding rounds.
Poxel's investors include Mailys Ferrere, InnoBio, Omnes Capital, Olivier Martinez, Bruno Montanari.
Poxel has raised $50.3M across 3 funding rounds. Most recently, it raised $12.9M Series B Extension in September 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 9, 2014 | $12.9M Series B Extension | Mailys Ferrere | |
| Dec 21, 2012 | $17.1M Series B | InnoBio, Omnes Capital | |
| Jul 8, 2010 | $20.3M Series A | Olivier Martinez, Bruno Montanari |